Tag: Winance
Genomic Vision: drawing of the 2nd tranche of 2 ME under the financing program in the form of OCABSA concluded with Winance
By Hector Chaunu Published on 02/17/2023 at 6:23 p.m. Photo credit © Monnaie de Paris (Boursier.com) —…
Genomic Vision announces the drawing of the first tranche of €2 million under the financing program concluded with Winance for a maximum amount of €30 million – 09/06/2022 at 6:00 p.m.
Bagneux (France) – Genomic Vision (FR0011799907 – GV, PEA-PME eligible), a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications (the “Company”), announces…
Genomic Vision: new line of financing with Winance
(Boursier.com) — Genomic Vision, a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications, announces today the establishment of a new line of…
Genomic Vision: drawdown of two new tranches for € 2 million as part of the financing program concluded with Winance – 12/24/2021 at 6:00 p.m.
It is recalled that in the context of a press release dated June 15, 2020, the Company announced the signing of an issue contract on June 11, 2020 with Winance…
Genomic Vision announces the drawing of two new installments for 2 M ?? within the framework of the financing program concluded with Winance for a maximum amount of 12 M ??
Regulatory News: Genomic Vision (FR0011799907 – GV, eligible for PEA-PME) (Paris: GV), a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications (the…